You can buy or sell ORIC and other stocks, options, and ETFs commission-free!
Oric Pharmaceuticals, Inc. Common Stock, also called Oric Pharmaceuticals, is a clinical stage company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. Read More It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in 2014 and is headquartered in South San Francisco, CA. The listed name for ORIC is Oric Pharmaceuticals, Inc. Common Stock.
South San Francisco, California
52 Week High
52 Week Low
— per share
Expected Nov 4, After Hours